A
A

AstraZeneca

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

UK Stocks-Factors to watch on July 30

July 30 (Reuters) - Britain's FTSE 100 .FTSE index is seen opening lower on Friday, with futures FFIc1 down 0.6%. * BHP: BHP Group Ltd BHP.AX said it would build two solar farms and a battery storage system in partnership with Canada's TransAlta Renewables Inc RNW.TO at its nickel project site in Western Australia. * ASTRAZENECA: Japan approved the
A
G
I
J
P
R
U

First batch of U.S. donated Pfizer vaccines arrives in Thailand

BANGKOK, July 30 (Reuters) - Thailand received its first batch of 1.5 million doses of Pfizer PFE.N COVID-19 vaccines donated by the U.S. government on Friday, as the Southeast Asian country battles its biggest COVID-19 outbreak to date. Since April, Thailand has been tackling a surge in infections driven by the highly contagious Delta variant of t
A
P

British Business - July 30

July 30 (Reuters) - The following are the top stories on the business pages of British newspapers. Reuters has not verified these stories and does not vouch for their accuracy. The Times - Amazon.com Inc AMZN.O signalled last night that its breakneck growth will slow over the coming months as people emerge from pandemic restrictions. Link - Sales o
A
A
L

UK Stocks-Factors to watch on July 29

July 29 (Reuters) - Britain's FTSE 100 .FTSE index is seen opening lower on Thursday, with futures FFIc1 up 0.21%. * DRAX: Drax DRX.L announced a 10% increase to its interim dividend as profits rose and the financial impact of COVID-19 on the business softened. * COMPASS GROUP: Compass Group CPG.L forecast trading to be around 80% to 85% of pre-pan
A
B
C
D
D
R
S
A
U

AstraZeneca Says Half-Year 19 Revenue Jumped To Nearly $1.2 Bln

July 29 (Reuters) - AstraZeneca PLC AZN.L : * AZN: H1 2021 RESULTS * H1 EARNINGS PER SHARE ROSE 37 PERCENT TO 1.61 USD * OUR LONG-TERM GOALS TO ACCELERATE SCIENTIFIC DISCOVERY, INVEST FOR SUSTAINABLE GROWTH AND DELIVER MORE BENEFITS FOR PATIENTS REMAINS UNCHANGED * TOTAL REVENUE IS EXPECTED TO INCREASE BY A LOW-TWENTIES PERCENTAGE, ACCOMPANIED BY A
A

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

We are using cookies to give you the best experience on our website. Read more or change your cookie settings.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.